Trials / Completed
CompletedNCT00545064
Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED)
A Multicenter, Open-Label Study To Evaluate The Tolerability Of Preservative Free Dorzolamide-Timolol Therapy In Patients Untreated With Open-Angle Glaucoma Or Ocular Hypertension And Dry Eye(s)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 176 (actual)
- Sponsor
- Merck Sharp & Dohme LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate if preservative free cosopt is well tolerated in patients with Open angle glaucoma (OAG) or Ocular hypertension (OH) with dry eyes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | dorzolamide hydrochloride (+) timolol maleate | dorzolamide hydrochloride (2%)/ timolol maleate (0.5%) Preservative free twice a day (BID), for 8 weeks of treatment |
Timeline
- Start date
- 2007-05-23
- Primary completion
- 2008-09-15
- Completion
- 2008-09-15
- First posted
- 2007-10-17
- Last updated
- 2017-06-20
- Results posted
- 2010-02-01
Source: ClinicalTrials.gov record NCT00545064. Inclusion in this directory is not an endorsement.